SEC Comment Letter for InflaRx N.V. (IFRX) (CIK 0001708688) (IFRX) — Oct 31, 2017
InflaRx N.V. (IFRX) (CIK 0001708688)
Date: Oct. 31, 2017 · CIK: 0001708688 · Accession: 0000000000-17-038396
AI Filing Summary & Sentiment
File numbers found in text: 333-220962
Show Raw Text
October 30, 2017
Niels Riedemann
Chief Executive Officer
Fireman B.V.
Winzerlaer Str. 2
07745 Jena, Germany
Re:Fireman B.V.
Amendment No. 2 to Registration Statement on Form F-1
Filed October 30, 2017
File No. 333-220962
Dear Mr. Riedemann:
We have reviewed your amended registration statement and have the following
comments. In some of our comments, we may ask you to provide us with information so we
may better understand your disclosure.
Please respond to this letter by amending your registration statement and providing the
requested information. If you do not believe our comments apply to your facts and
circumstances or do not believe an amendment is appropriate, please tell us why in your
response.
After reviewing any amendment to your registration statement and the information you
provide in response to these comments, we may have additional comments. Unless we note
otherwise, our references to prior comments are to comments in our October 27, 2017 letter.
Amendment No. 2 to Registration Statement on Form F-1
Summary consolidated historical and other financial information, page 10
1.Pro forma net loss per share should only be presented for the latest year and interim
period. Please delete pro forma net loss per share of 2015 and the six months ended June
30, 2016.
Dilution, page 78
2.You state in the paragraph following the table on page 79 that "Each $1.00 increase
(decrease) in the offering price per share, respectively, would increase (decrease) the total
FirstName LastNameNiels Riedemann
Comapany NameFireman B.V.
June 16, 2017 Page 2
FirstName LastName
Niels Riedemann
Fireman B.V.
October 30, 2017
Page 2
consideration paid by new investors by approximately $6.2 million (€5.4 million) and
increase (decrease) the percentage of total consideration paid by new investors by
approximately 1.6%, assuming that the number of shares offered by us, as set forth on the
cover page of this prospectus, remains the same. Similarly, each increase (decrease) of
1.0 million shares offered by us at the assumed initial public offering price would
increase (decrease) the percentage of total consideration paid by new investors by
approximately 3.3%." Tell us why the increase (decrease) in total consideration would
not be $6.7 million, 6.7 million shares times $1. Also, provide us your computation of
the 1.6% and 3.3% and revise as necessary.
You may contact Mark Brunhofer at 202-551-3638 or Lisa Vanjoske at 202-551-3614 if
you have questions regarding comments on the financial statements and related matters. Please
contact Dorrie Yale at 202-551-8776 or Erin Jaskot at 202-551-3442 with any other questions.
Division of Corporation Finance
Office of Healthcare & Insurance
cc: Sophia Hudson